Medpace CEO August J. Troendle sells 10,880 shares for $6.75 million

• Medpace Holdings President and CEO August J. Troendle sold 10,880 common shares on Sept. 17, 2026.
• The sale price was USD 620.4 per share.
• Troendle’s directly held stake fell to 504,273 shares.
• He also reported 4.73 million shares held indirectly through Medpace Investors.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medpace Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001622058-26-000014), on September 21, 2026, and is solely responsible for the information contained therein.